SastiMedic
Advog 0.2mg Tab 10s

Advog 0.2mg Tab 10s

MRP: ₹0.00

Packaging

TAB

Composition

Voglibose 0.2mg

Company

Eris Lifesciences

Buy Now

Substitutes for Advog 0.2mg Tab 10s

Medicine Company Price You Save
Megabose 0.2mg Tab 10s Aristo Pharma ₹20.00
Starvog 0.2mg Tab 10s Merck India ₹25.00
Volicose 0.2mg Tab Biocon Ltd ₹33.00
Voglitab MD 0.2mg Tab 10s Intas ₹35.00
Prandial 0.2 mg Tablet 10s Cipla ₹38.00
Zibose 0.2mg Tablet 10s FDC ₹48.40
V Glib 0.2mg Tablets Md 10s Aamorb Pharmaceuticals Pvt. Ltd. ₹59.50
Voglimac 0.2mg Tab 10s Macleods ₹60.00
Obiglo MD 0.2 Tablet Abbott India ₹62.00
Voglitor 0.2mg Tab Torrent Pharma ₹62.00
Voglitab 0.2mg Tab 10s Intas ₹64.00
Vogo 0.2mg Tab 10s Alembic Pharma ₹64.10
Glyvog 0.2mg Tablet 10s Bal Pharma ₹65.00
Vigocil 0.2mg Tablet 10s ASTRA ZENECA ₹66.80
Vocarb 0.2mg Tab 10s Glenmark ₹70.20
Vobose 0.2mg Tab 10s USV ₹70.53
Vingose 0.2 Tab Novartis India ₹73.35
Voglinorm 0.2 mg Tablet 10s Micro Labs ₹74.00
Volix Instab 0.2mg Tab 10s Ranbaxy ₹74.70
Megavog 0.2mg Tablet 30s Aristo Pharma ₹77.00
Posmeal MD 0.2mg Tab 10s Unichem ₹77.48
Volibo 0.2mg Tab 10s Sun Pharma ₹85.50
Vobit 0.2mg Tab 10s Lupin ₹88.50
Voglitor MD 0.2mg Tab 10s Torrent Pharma ₹88.70
Vobit MD 0.2mg Tab 10s Lupin ₹96.50
Oglibo MD 0.2 Tab 20s Panacea Biotec ₹109.00
Vozuca 0.2mg Tab 10s Dr. Reddy ₹123.00
Volix-0.2mg Tab 10s Sun Pharma ₹131.25
PPG 0.2 mg Tablet 30s Abbott India ₹148.40
Vozuca Active 0.2 Tablet 60s Dr. Reddy ₹196.50

Uses of Advog 0.2mg Tab 10s

Voglibose is used in the treatment of diabetes. Voglibose reduces absorption of glucose from the intestine and thus lowers post-prandial glucose level .

Side Effects of Advog 0.2mg Tab 10s

Flatulence; abdominal distension; diarrhoea; pain; skin reactions; hypoglycemia; increased LFT. Potentially Fatal: Hepatotoxicity.

Drug Interactions

May enhance effects of other antidiabetics including insulin.

Contraindications

Inflammatory bowel disease; GI obstruction or patients predisposed to it; conditions which may deteriorate as a result of increased gas formation eg, hernia; severe ketosis; diabetic coma or pre-coma; severe infection; hypersensitivity; pregnancy; lactation. Not to be used as monotherapy in IDDM.

Mechanism of Action

Voligbose has general properties similar to acarbose and selectively inhibits α-glucosidase in the enteric canal, delaying the digestion and absorption of carbohydrate, thereby suppressing sharp increase in post-prandial plasma glucose.

Special Precautions

History of laparotomy or ileus. Roemheld's syndrome, stenosis, severe hepatic or renal impairment. Child <18 yr; elderly. Monitor LFT. Treat hypoglycaemic episodes with glucose (not with sucrose).

How to Use

Take orally with food and water, as directed by your physician.

How to Store

Keep in a cool, dry place away from sunlight and moisture.

Safety Concerns

  • Alcohol: Avoid during treatment.
  • Breastfeeding: Not recommended.
  • Pregnancy: Contraindicated.
  • Liver/Kidney: Use with caution.

Content Disclaimer

This content is for educational purposes only. Please consult your doctor before use.

More brands by Eris Lifesciences

Written by: SastiMedic Medical Team

Reviewed by: Registered Pharmacist